{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Cho HJ"],"pubmed_abstract":["<b>Background:</b> Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010-2019. <b>Methods:</b> We analyzed the outpatient care of persons aged ≥65 years covered by National Health Insurance (NHI) using NHI claims data from 2010 to 2019. Polypharmacy was defined as the use of ≥5 medications, and hyper-polypharmacy was defined as the use of ≥10 medications, and we examined them over periods of ≥90 days and ≥180 days. The average annual percent change (AAPC) was calculated using Joinpoint statistical software. <b>Results:</b> The prevalence of polypharmacy among ≥90 days of medication use elderly decreased from 42.5%"],"journal":["Frontiers in pharmacology"],"pagination":["866318"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9124766"],"repository":["biostudies-literature"],"pubmed_title":["Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010-2019."],"pmcid":["PMC9124766"],"pubmed_authors":["Yoon SH","Kim DS","Chae J","Cho HJ"],"additional_accession":[]},"is_claimable":false,"name":"Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010-2019.","description":"<b>Background:</b> Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010-2019. <b>Methods:</b> We analyzed the outpatient care of persons aged ≥65 years covered by National Health Insurance (NHI) using NHI claims data from 2010 to 2019. Polypharmacy was defined as the use of ≥5 medications, and hyper-polypharmacy was defined as the use of ≥10 medications, and we examined them over periods of ≥90 days and ≥180 days. The average annual percent change (AAPC) was calculated using Joinpoint statistical software. <b>Results:</b> The prevalence of polypharmacy among ≥90 days of medication use elderly decreased from 42.5%","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-22T11:57:26.08Z","creation":"2025-02-18T23:19:45.297Z"},"accession":"S-EPMC9124766","cross_references":{"pubmed":["35614938"],"doi":["10.3389/fphar.2022.866318"]}}